Toni Nesci has been appointed Head of Mayne Contract Services, a division of 
the Mayne Pharma family. Mayne Contract Services, based in Salisbury, South 
Australia is the full-service pharmaceutical development and manufacturing 
business unit created to serve clients worldwide by leveraging more than 40 
years of scientific expertise in developing complex oral and topical dose forms.

Mayne Pharma President of International Operations Stefan Cross said, "Toni's 
appointment comes as the Company is experiencing strong growth in new clients 
and projects. Mayne Pharma has a long-standing reputation for world class 
product development and leadership, and we will continue to deliver on those 
promises for our clients." 

Toni has over 20 years of pharmaceutical industry experience across strategy, 
business development, project management and new product launch. She has held a 
variety of roles at Pfizer and Hospira and most recently supported the 
successful launch of several US and global products at Pfizer. Educated in 
Adelaide, Mayne Pharma is delighted to return Toni's global industry experience 
to South Australia.

The Company launched a new website this week for Mayne Contract Services 
(www.maynecontractservices.com) showcasing the development and manufacturing 
capabilities of the Salisbury, South Australia facility.

About Mayne Contract Services

Mayne Contract Services is the full-service pharmaceutical development and 
manufacturing business unit serving clients worldwide with more than 40 years 
of scientific expertise in developing complex oral and topical dose forms 
including modified-release products, poorly soluble compounds and highly potent 
compounds.

Mayne Contract Services areas of expertise include quality pharmaceutical 
formulation development, first-time-in-man formulations; Phase I-III clinical 
trial manufacturing; and analytical method development and validation services 
leading to commercial scale manufacturing. Located in Salisbury, South 
Australia, Mayne Contract Services is a proud member of Mayne Pharma. Learn 
more at www.maynecontractservices.com.au 

About Mayne Pharma

Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on 
applying its drug delivery expertise to commercialise branded and generic 
pharmaceuticals, offering patients better and more accessible medicines. Mayne 
Pharma also provides contract development and manufacturing services to more 
than 100 clients worldwide.

Mayne Pharma has a 40-year track record of innovation and success in developing 
new oral drug delivery systems and these technologies have been successfully 
commercialised in numerous products that continue to be marketed around the 
world. 

Mayne Pharma has two facilities based in Salisbury, Australia and Greenville, 
USA with expertise in the formulation of complex oral and topical dose forms 
including potent compounds, modified-release products and poorly soluble 
compounds.

SOURCE: Mayne Pharma